Treatment of Rheumatoid Arthritis by TNF-Blocking Agents

Publisher： Karger

E-ISSN： 1423-0097|127|1|10-14

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.127, Iss.1, 2002-02, pp. : 10-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis

By Haberhauer Guenther

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 220-224

Springer Publishing Company

Access to resources Recommend Favorite

Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

By Hochberg Marc C. Berry Scott Broglio Kristine Rosenblatt Lisa Nadkarni Anagha Trivedi Digisha Hebden Tony

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1213-1222

Informa Healthcare

Access to resources Recommend Favorite

Treatment of early rheumatoid arthritis

By Raza Karim Salmon Mike Buckley Christopher D

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 659-668

Future Medicine

Access to resources Recommend Favorite

Certolizumab pegol for the treatment of rheumatoid arthritis

By Modesto I Spinello M Nicchi F Cottone M

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

Subcutaneous abatacept for the treatment of rheumatoid arthritis

By Schiff Michael

British Journal of Rheumatology , Vol. 52, Iss. 6, 2013-06 ,pp. : 986-997

Oxford University Press

Access to resources Recommend Favorite